Fungemia overview

Revision as of 17:19, 7 December 2012 by Kalsang Dolma (talk | contribs)
Jump to navigation Jump to search

Fungemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Fungemia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fungemia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Fungemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fungemia overview

CDC on Fungemia overview

Fungemia overview in the news

Blogs on Fungemia overview

Directions to Hospitals Treating Fungemia

Risk calculators and risk factors for Fungemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Fungemia is the presence of fungi or yeasts in the blood. It is most commonly seen in immunosuppressed or immunocompromised patients with severe neutropenia, oncology patients, or in patients with intravenous catheters. Recently, it has been suggested the otherwise immunocompetent patients taking infliximab may be at a higher risk for fungemia.

Causes

The most commonly known pathogen

References

Template:WH Template:WS